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ORIGINAL ARTICLE
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ABSTRACT
Purpose: To determine the prevalence of viral infections in patients with hypertensive anterior uveitis in
Thailand from polymerase chain reaction (PCR) of aqueous humor.
Methods: Thirty-one patients with anterior uveitis with intraocular pressure (IOP) above 25 mmHg were
included for PCR analysis for cytomegalovirus (CMV), herpes simplex (HSV), varicella-zoster (VZV), rubella,
chikungunya and Zika virus.
Results: The prevalence of PCR-positive results was 32%, including 19% for CMV, 10% for HSV, and 3% for
VZV; PCR for other tested viruses demonstrated negative results. PCR-positive patients exhibited satisfactory
IOP control with antiviral and anti-glaucomatous treatment compared to PCR-negative patients, and more than
half of PCR-negative patients required glaucoma surgery within 12 months (P = .01).
Conclusion: PCR evidence of infection with herpes group viruses was found in one-third of patients with
hypertensive anterior uveitis; CMV being the most common pathogen. The PCR-positive group generally
responded well to a combination of antiviral and anti-glaucoma treatment.
Keywords: Cytomegalovirus, herpes simplex virus, hypertensive anterior uveitis, polymerase chain reaction,
varicella-zoster virus
Anterior uveitis (AU) represents the most common
type of uveitis worldwide.1 Causes of AU vary
widely, from noninfectious entities (such as HLA B27-
associated AU or sarcoidosis) to numerous
infections.2 Viral agents were repeatedly detected in
the intraocular fluid of patients with AU, especially in
patients with unilateral hypertensive anterior uveitis
(HAU), who were resistant to standard topical treat-
ment with corticosteroids.3,4 Multiple viral causes of
AU were reported, the most common being members
of the herpes virus group. Rubella virus (RV) was
demonstrated in Europe and other countries and
emerging viral agents as chikungunya, Zika, and
Ebola viruses were also implicated.5 Viral AU mani-
fests predominantly as unilateral HAU often asso-
ciated with some form of iris atrophy.6
We performed a retrospective study of 31 consecu-
tive HLA B27-negative patients with HAU in
Thailand and examined the clinical manifestations of
patients positive for PCR outcomes and compared
their features to patients with negative results.
METHODS
In this study, 31 patients with HAU were included,
seen between October 2016 and January 2019 in the
ophthalmology department of Chiang Mai University
Hospital, Thailand. HAU patients were selected from
a cohort of 110 uveitis patients who underwent aqu-
eous polymerase chain reaction (PCR) examinations
in the same period.
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All patients with uveitis underwent a diagnostic
workup, which included erythrocyte sedimentation
rate, complete blood counts, serology for syphilis,
toxoplasma and HIV, chest X-ray and tuberculin
skin test. Also, HLA-B27 testing was performed in
AU and panuveitis cases. Classification of uveitis
was performed according to SUN criteria.7 AU
patients with inconclusive results of initial workup
and with clinical suspicion of a viral infection (such
as active or recurrent unilateral AU not responding to
topical corticosteroids) underwent the aqueous tap for
PCR examinations.
HAU was defined as AU with IOP equal to or more
than 25 mmHg in the affected eye. HAU patients with
a prior diagnosis of glaucoma or steroid-induced ocu-
lar hypertension were excluded. Data on clinical man-
ifestations were selected from patients’ files. We
registered the results of complete ocular examina-
tions, including best-corrected visual acuity (BCVA),
IOP, as well as the results of slit lamp examination of
both anterior and posterior segments and indirect
fundoscopy. In addition, we registered BCVA
changes and all complications during one-year fol-
low-up after the aqueous examination has been per-
formed. None of the patients with HAU had retinal
inflammatory lesions. In cases with bilateral involve-
ment, only the eye with the highest IOP was evalu-
ated. Diagnosis of Posner-Schlossman Syndrome
(PSS) was made in cases with unilateral mild iritis
with fine keratic precipitates, diffuse corneal epithe-
lial edema, and highly elevated IOP (>40 mmHg).
Fuchs Uveitis Syndrome (FUS) was diagnosed as in
the presence of at least four of the following five
signs: (1) unilateral low-grade AU without acute red-
ness, (2) typical scattered keratic precipitates, (3)
absence of synechiae, (4) diffuse iris atrophy, and (5)
cataract.6
Polymerase chain reaction for CMV, HSV-1, HSV-
2, VZV, RV, chikungunya, and Zika viruses was per-
formed in all aqueous fluid samples from included
patients. Real-time PCR for CMV, HSV-1, HSV-2, and
VZV was performed as described previously.8,9
Briefly, nucleic acid was extracted from 25 μl of aqu-
eous fluid using a commercially available kit,
QIAamp® DNA Blood Mini Kit (QIAGEN, Inc.,
Valencia, CA, USA) according to the manufacturer’s
instruction and stored until use in aliquots at −80□C.
For assurance and monitor the quality of extraction
and the amplification procedures, 2,500 to 5,000
copies/mL of Phocid herpes virus type 1 (PhHV-1)
were added to each sample before extraction.10 The
detection of each investigated pathogenic DNA was
performed at the Division of Clinical Microbiology,
Department of Medical Technology, Faculty of
Associated Medical Sciences, Chiang Mai University,
Chiang Mai, Thailand, as described previously.9,11
The forward primers, reward primers and probes
specific for CMV, HSV-1, HSV-2 and VZV as follow-
ing, F-GCCGATCGTAAAGAGATGAAGAC, R-CT
CGTGCGTGTGCTACGA GA, P-(5HEX)AGTGCAG
CCCCGACCATCGTTC(BHQ1a~5HEX), F-TCCACC
AGG ACCACGTAG, R-CTGTCGCCTTACGTGAAC
AAGAC, P-(6~ FAM)CCCGTCTCCAT GTCCAG
GATGGG(TAMRA~6~ FAM), F-TCCACGAGGACC
ACGTAGG, R-CTG GCGCCTTACGTGAACAAGAC,
P-(6~ FAM)CCCGTCTCCATGTCCAGGACGGG (TA
MRA~6~ FAM), F-AAGTTCCCCCCGTTCGC, R-TGG
ACTTGAAGATGAACT TAATGAAGC and P-(6~
FAM)CCGCAACAACTGCAGTATATATCGTC (TA
MRA~6~ FAM), respectively. Briefly, 10 μl of the
extracted nucleic acid was added to 15 μl of the real-
time PCR reaction mixture (DyNAmo Probe qPCR;
New England Biolabs, Inc), which contains specific
primers and probes. Then, real-time PCR was per-
formed in a real-time PCR machine (CFX96™ Real-
time System; Bio-Rad). The PCR analysis for RV,
chikungunya and Zika viruses was performed in
Erasmus Medical Center as reported previously.12–14
Treatment regimens for CMV-positive HAU
included 2% topical ganciclovir (4 to 6 times/day
during the first month, followed by 4 times/day for
2 to 3 months and 3 times/day for additional
3 months). Treatment duration was at least 6 months;
no systemic or intravitreal treatments were given.
Treatment for HSV and VZV HAU included a 3%
acyclovir ointment (5 times/day for 6 weeks and
tapered to 2 to 3 times/day for up to 4 months)
together with systemic acyclovir (800 mg twice
a day for 6 to 8 weeks, followed by 400 to 800 mg
daily for 4 months). Topical corticosteroids and IOP
lowering drugs were added according to the severity
of inflammation and IOP values.
This study was done in accordance with the tenets
of the Declaration of Helsinki, and the study protocol
was approved by the ethics board of Maharaj Nakorn
Chiang Mai Hospital, the Chiang Mai University.
Statistical Analysis
Quantitative data were reported as mean (±SD) while
categorical variables are analyzed using the Chi-
square test, and quantitative difference between
groups analysis using the Paired t-test. A P-value
<0.05 was considered to be statistically significant.
RESULTS
Demographic data and clinical characteristics of
included patients are illustrated in Table 1. The
most frequent complaint consisted of blurred
vision, less prevalent were redness and pain.
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Most patients suffered from unilateral HAU. No
differences were found in gender or age. The most
common anterior segment findings included
small to medium-sized white/gray keratic preci-
pitates (KPs) and a mild anterior chamber inflam-
mation. The only case of HAU with hypopyon was
later diagnosed with Behçet’s disease. Despite the
high IOP at the onset, only five eyes had at that
time a cup-to-disc ratio ≥ 0.7. At the first presenta-
tion in our department, eight patients already
underwent cataract surgery. Out of 23 phakic
eyes, 16 (52%) had cataract at initial presentation.
Cystoid macular edema was not present.
Positive PCR resultswere found in 10/31 (32%) patients
(CMV = 6, HSV = 3, and VZV = 1). None of the patients
was positive in PCR for RV, chikungunya, and Zika virus.
No complications of anterior chamber tap were encoun-
tered, such as endophthalmitis, lens injury, and hemor-
rhage. Out of the remaining PCR negative patients, only
one patient received a definitive diagnosis (Behçet’s dis-
ease), and the others remained of unknown origin.
Patients with CMV-positive HAU had all mild
AC reaction and small to medium-sized KPs.
Clinical features were not distinct from HAU asso-
ciated with HSV, VZV, or PCR negative AU
group. In CMV-positive HAU, IOP was commonly
well controlled with medication. None of our
CMV-positive HAU patients needed glaucoma sur-
gery during the first year of follow-up (Table 2).
All affected eyes in HSV/VZV group exhibited
corneal involvement, out of which two eyes required
corneal transplantation during the follow-up. IOP
range was similar to CMV-positive HAU, and none
of the patients needed filtering surgery for glaucoma
within one year of follow-up. Interestingly, one 28-
year-old female with unilateral HAU was found posi-
tive for HSV-2. She reported no associated general
symptoms and was not known with any comorbidity.
This patient demonstrated a low-grade unilateral
anterior chamber inflammation, fine KPs, and pre-
senting IOP of 28 mmHg, but responded well to
TABLE 1. Characteristics of patients with hypertensive anterior uveitis according to polymerase chain reaction results.
Characteristic
Total HAU
N = 31
CMV-DNA
positive
N = 6
HSV/VZV-DNA
positive
N = 4
PCR-
negative
N = 21 P-value**
Mean age of onset 50.54 ± 11.85 51 ± 11.04 51.25 ± 15.06 50.28 ± 12.13 0.985
Male 18 (58%) 4 (67%) 1 (25%) 13 (72%) 0.349
Redness/pain 9 (29%) 4 (67%) 1 (25%) 4 (19%) 0.075
Corneal involvement 11 (35.5%) 2 (33%) 3 (75%) 6 (28.5%) 0.204
Scars 2 (6.5%) 0 0 2 (9.5%)
Edema 6 (19%) 1 (17%) 2 (50%) 3(14.%)
Endotheliitis 3 (10%) 1 (17%) 1 (25%) 1(5%)
Small to medium-sized keratic precipitates 20 (65%) 4 (67%) 2 (50%) 14 (67%) 0.809
Anterior chamber cells 0.866
2+ 26 (84%) 5 (83%) 3 (75%) 18 (86%)
2+ 5 (16%) 1 (17%) 1 (25%) 3 (14%)
Iris involvement
Posterior synechiae 3 (10%) 1 (17%) 0 2 (9.5%) 0.682
Iris atrophy 9 (29%) 4 (67%) 1 (25%) 4 (19%) 0.075
Cataract at first presentation 16 (52%) 1 (17%) 2 (50%) 13 (62%) 0.147
Average highest IOP
(Range)
33 mmHg
(25–46)
30 mmHg
(23–33)
28.5 mmHg
(26–31)
34 mmHg
(25–46)
0.098
CMV: Cytomegalovirus, HSV: Herpes simplex virus, VZV: Varicella zoster virus, HAU: Hypertensive anterior uveitis, PCR:
Polymerase chain reaction, IOP: Intraocular pressure
*There were 8 patients who underwent cataract surgery before their first presentation in our center
**PCR positive versus PCR negative patients
TABLE 2. Development of new complications and intraocular
surgeries in patients with hypertensive anterior uveitis during
a follow-up of 12 months after initial presentation.
CMV-
positive
N = 6
HSV/VZV-
positive
N = 4
PCR-
negative
N = 21 P-value*
New
complications
● Cataract 1 (17%) 0 1 (5%) 0.49
● Glaucoma 1 (17%) 0 12 (57%) 0.03
● Corneal
decompensation
1 (17%) 2 (50%) 5 (24%) 0.46
Intraocular
surgeries
●Cataract surgery 1 (17%) 0 1 (5%) 0.49
●Glaucoma
filtering surgery
0 0 11 (52%) 0.01
●Corneal
transplantation
1 (17%) 1 (25%) 3 (14%) 0.86
CMV: Cytomegalovirus, HSV: Herpes simplex virus, VZV:
Varicella zoster virus, PCR: Polymerase chain reaction
*PCR positive versus PCR negative patients
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treatment and did not develop any complications
during the 12 months.
Out of 21 HAU patients negative for tested
viruses, two (9%) exhibited large mutton fat KPs.
Though the clinical manifestations of PCR-negative
patients did not differ from the PCR positive group,
IOP of PCR-negative HAU patients was often not
adequately controlled with medication and required
surgical intervention in 11/21 (52%) during the first
follow-up year (Table 2).
Iris atrophy was documented in 9/31 (29%)
patients (4 positive for CMV, 1 for HSV, and 4
were PCR negative). Diffuse iris atrophy was more
frequently seen (n = 6), and a sector iris atrophy was
observed in 3 CMV-positive cases, of whom 2
already underwent cataract extraction. Posterior
synechiae developed in 3/31 (10%) eyes (1 CMV-
positive and 2 PCR-negative cases) and ranged up
to 90 degrees.
Visual Prognosis and Complications
At baseline, 7/31 (22%) patients had visual acuity of
less than 0.1. At six months follow-up, 2/31 patients
had VA < 0.1 (both due to corneal opacities) and at
12 months, one additional patient developed VA less
than 0.1 due to bullous keratopathy. In our series,
glaucoma did not cause central vision loss. During
the first year of follow-up, 18/31(35%) HAU patients
needed at least one surgical intervention (2 cataract
extractions, five corneal transplantations, and 11 fil-
tering surgery for glaucoma; Table 2). Eight patients
underwent cataract extraction before the referral.
Development of cystoid macular edema was not
observed.
DISCUSSION
Our study of HAU patients from Thailand shows that
one-third of patients were positive in PCR analysis for
herpes viruses, most commonly for CMV, but none
were found positive for RV, chikungunya, and Zika
viruses.
Our results are analogous to previous studies from
Asia, which all showed that CMV was the most com-
mon agent found by PCR in intraocular fluid samples
of HAU patients. The prevalence of CMV in HAU in
our series was 19%, which is consistent with previous
results from Asia, which varied between 23-34%
(Table 3).15–19 Miyazaki et al. used different inclusion
criteria and reported a prevalence of 18% of CMV in
anterior uveitis and 35% in patients with endotheliitis
[ref].17 The differences in PCR detection levels might
have influenced our somewhat lower prevalence of
CMV. We used only 25μl of aqueous humor for DNA
extraction and might have had more positive results
with a larger volume.
Our findings suggest that chikungunya and Zika
viruses do not frequently cause HAU in Thailand. The
chronic character of RV-associated uveitis might
explain the absence of positive PCR results for RV
virus. The previous study from Thailand showed
that 24% of intraocular fluid samples of AU patients
tested by GWC for RV were found positive, but none
exhibited positive PCR result.11 The low prevalence of
positive PCR results for RV was also documented in
other areas of the world.14
Clinical features in our HAU population are
consistent with earlier reports; specifically, HAU
was predominantly unilateral and had no gender
predilection. The clinical manifestations of PCR
positive patients were not distinct for the HAU
with negative PCR results. It has been previously
suggested that differentiation between specific
herpes viruses cannot be based solely on the clin-
ical features. However, corneal involvement was
reported to be common in AU associated with
HSV and VZV, which was also observed in the
present series.19–21 While most studies do not dis-
tinguish between HSV-1 and HSV-2 infection, one
remarkable finding in this study was a positive
HSV-2 PCR. Although both HSV-1 and HSV-2
can cause ocular infections, HSV-2 is more com-
monly associated with acute retinal necrosis and
congenital infections. Therefore, to find the HSV-2
in a young female with HAU was surprising and
indicated that HSV2 might also cause anterior
uveitis only.
In our series, none of the PCR-positive patients
required glaucoma surgery during the first year of
TABLE 3. Comparison of specific viral infections in patients
with hypertensive anterior uveitis in recent studies from Asia.
Author Year
Number
of
patients
CMV
%
HSV
%
VZV
%
Other
viral
agents
(%)
Our study 2019 31 19 10 3 N/a
Keorochana
N et al.15
2019 64 34 6.3 11 1.6
(EBV)
Hsiao
Y-T et al.16
2019 102 27 8.8 5 1 (EBV)
Miyazaki
D et al.17
2018 197 18 (AU) N/a N/a N/a
Choi JA
et al.18
2016 42 29 N/a N/a N/a
Chee S-P
et al.19
2008 105 23 N/a N/a N/a
CMV: Cytomegalovirus, HSV: Herpes simplex virus, VZV:
Varicella zoster virus, EBV: Epstein Barr virus, AU: Anterior
uveitis, N/a: not applicable
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follow-up. In contrast, more than half of patients
with negative PCR results developed uncontrolled
IOP despite the maximal medication and required
glaucoma surgery during the first year after the
presentation. It is feasible that the identified viral
causes of uveitis and the subsequent antiviral
treatment might have positively influenced the
low need for glaucoma surgery. This observation
is supported by a study from Hwang et al.,22 who
reported on well-controlled IOP in CMV positive
HAU patients treated with intravitreal ganciclovir.
However, Su et al. reported that 37% of their
CMV-positive HAU developed uncontrolled IOP
in the late stages and implied that the need for
glaucoma surgery in CMV HAU develops after
more than five years.23
Our study has the limitations typical for all retro-
spective studies. The investigations were not per-
formed at the previously determined intervals, and
the detailed clinical observations of iris atrophy and
subtle corneal changes might have been unnoticed or
underreported. Besides, our follow-up period was
limited. Like most studies, we included only PCR
examinations and did not determine Goldmann-
Witmer coefficient (GWC). Since GWC is typically
positive in the chronic phase of the disease, it is
conceivable that without the GWC determination,
the diagnosis in some patients, especially those pre-
senting in our hospital during the late phase of their
uveitis, could be missed. Lastly, the limited number
of PCR-positive cases and the lack of exact data on
viral loads precluded meaningful analyses of rela-
tionships between the viral loads and specific clin-
ical manifestations such as the development of
glaucoma.
The clinical findings suggesting the viral cause of
HAU included mostly unilateral involvement, mild
anterior chamber inflammation, small to medium
non-granulomatous KPs, some form of iris atrophy
(Figures 1 and 2). The absence of macular edema was
also well established. Patients presenting with these
clinical features, especially those with ongoing uvei-
tis activity despite the standard treatment with cor-
ticosteroid drops, might profit from PCR analysis of
aqueous fluid. Ideally, PCR should be combined
with GWC determinations.8 However, GWC deter-
mination requires also a serum sample, and the
laboratory procedure is complicated and requires
additional laboratory investments. One should rea-
lize that with PCR examination only, some chronic
viral infections could be missed as previously docu-
mented for RV.11
In conclusion, we show that PCR examinations
for HSV, VZV, and CMV revealed positive results
in one-third of patients with HAU while the nega-
tive PCR outcomes for RV, chikungunya, and Zika
were typical. The initial high IOP in patients with
positive PCR results was well controlled, possibly
also due to the adequate and early antiviral treat-
ment in addition to IOP lowering medications.
A prospective study with more patients and more
FIGURE 1. Keratic precipitates in viral hypertensive anterior
uveitis.(A). Fine keratic precipitates located at Arlt’s triangle.
(B). Coin-shaped endothelial lesions in cytomegalovirus-
associated anterior uveitis. (C). Linear keratic precipitates in
cytomegalovirus-associated anterior uveitis
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extensive intraocular fluid examinations might
reveal so far unknown causes of HAU and open
new avenues for its treatment.
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